Salute e Benessere

XRP Healthcare Secures Major Media Partnership with Global Exhibition Titans

Kain Roomes, CEO at XRP Healthcare said: Kain Roomes, CEO at XRP Healthcare said: "Our partnership with ACE Group and Genesis Global Exhibitions will significantly enhance the visibility of XRP Healthcare Magazine. This increased exposure will help us connect with industry leaders and innovators, driving the value and impact of XRP Healthcare." ACE Group has solidified its reputation as one ofIndia'sleading exhibition organizers, with over eight years of experience in the industry...
PR Newswire
26/07/2024

Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer

“After an extensive search, we are delighted to have Leone Patterson join us at this exciting time as we plan for our next stage of growth and development at Zymeworks,” said Kenneth Galbraith, Chair and CEO of Zymeworks. “She brings more than 20 years of public company biotech experience with a proven track record of guiding strategy, finance, operations, and governance through multiple phases of growth, planning and executing successful financial strategies. Ms. Patterson has the...
Nasdaq GlobeNewswire
25/07/2024

FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to…

ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated 1 There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transplantation (HSCT) or relapse afterFDA ODD and RPDD designations for UCART22 marks an important step towards developing allogeneic CAR T products that would be readily available for all patients...
Nasdaq GlobeNewswire
25/07/2024

Inventiva secures a new patent in Japan, expanding the IP protection of its lead…

Japanese Patent Office approved Inventiva's patent application relating to the use of lanifibranor for the treatment of cirrhosis. 1 This patent strengthens Inventiva's intellectual property with respect to lanifibranor in Japan for the indication cirrhosis, including cirrhosis due to MASH/NASH.Daix (France), Long Island City (New York, United States), July 25, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical...
Nasdaq GlobeNewswire
25/07/2024

Immunovia presents data from discovery study at 2024 PancreasFest medical…

Results presented at PancreasFest reflect a detailed scientific presentation of the initial positive data the company shared in a 7 November 2023 press release. Results presented at PancreasFest reflect a detailed scientific presentation of the initial positive data the company shared in a7 November 2023press release. The discovery study, the most comprehensive pancreatic cancer proteomics study done to date, identified 15 promising protein biomarkers that were shown to strongly...
PR Newswire
25/07/2024

Oxurion Share Consolidation

Oxurion Share ConsolidationLeuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV(Euronext Brussels: OXUR) (theCompany ), a biopharmaceutical company based in Leuven, announced today that its Board of Directors, authorized by the General Meeting of July 24, 2024, will proceed with a consolidation of all existing shares. This consolidation will be carried out at a ratio of one (1) new share for ten thousand (10,000) existing shares.This share consolidation is a strategic step to...
Nasdaq GlobeNewswire
25/07/2024

EssilorLuxottica: Q2/H1 2024 Results - Sound revenue growth, margins expanding…

Q2/H1 2024 ResultsSound revenue growth, margins expanding,two acquisitions in line with strategy Revenue growing by 5.2% in Q2 at constant exchange rates 1, +5.3% in H1EMEA as the driving region, North America keeping the pace of Q1Stellest in China and Ray-Ban Meta wearables continuing to grow exponentiallyAdjusted 2operating profit margin at 18.8%, up 50bps at constant exchange rates 1 Strong free cash flow 5generation, at Euro 971 million in...
Nasdaq GlobeNewswire
25/07/2024

GUERBET : H1 2024 revenue.

H1 2024 revenue Half-yearly activityH1 revenue: €419.2m, up 11.8% at CER 1, including an acceleration in Q2 (+14.5%)This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in France and MRI salesAnnual targets confirmedRevenue: expected growth of over 8% like-for-like and at CERProfitability: restated EBITDA margin rate 2higher than in 2021 (14.4%)Villepinte, 25 July 2024, 5.45 pm:Guerbet (FR0000032526 GBT), a global...
Nasdaq GlobeNewswire
25/07/2024

European regulatory authority adopts a positive opinion for an update of the…

Bagsværd, Denmark, 25 July 2024– Novo Nordisk today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy ®(semaglutide 2.4 mg) label to reflect data from the SELECT cardiovascular outcomes trial, demonstrating a risk reduction of major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack (myocardial infarction) or non-fatal stroke in...
Nasdaq GlobeNewswire
25/07/2024

Press Release: Online availability of Sanofi's half-year financial report for…

Online availability of Sanofi's half-year financial report for 2024Paris, July 25, 2024. Sanofi announces that its half-year financial report for the period ending June 30, 2024 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.This document may be found on the company's corporate website:www.sanofi.comand downloaded from the “Investors” page,...
Nasdaq GlobeNewswire
25/07/2024

Next-generation Sequencing Services Market to be Worth $24.44 billion by 2031-…

The growth of this market is mainly attributed to the reduced cost of NGS procedures, the development and approval of new targeted therapies, the rising prevalence of cancer, partnerships between NGS service providers and pharmaceutical companies, the high cost of sequencing infrastructure, and technological advancements in NGS. In addition, advancements in sequencing data analytics and the increasing applications of NGS in cancer and agri-genomics research are expected to offer significant…
PR Newswire
25/07/2024

Hair Extension Market to be dominated by North America and expected to reach…

Get your Sample PDF:https://www.stellarmr.com/report/req_sample/Hair-Extension-Market/2084 Get your Sample PDF: https://www.stellarmr.com/report/req_sample/Hair-Extension-Market/2084 Competitive Landscape The global hair extension market is competitive with several players including Great Lengths ( Italy ),Balmain Hair Couture( France ), Hairdreams ( Austria ), Bellami Hair ( USA ),Luxy Hair( Canada ), Easihair Pro ( USA ), SocapUSA( USA ),Cinderella Hair(UK),...
PR Newswire
25/07/2024

Digital Biomarkers Market Size to Hit USD 43.3 Billion by 2034, Projected a…

The digital biomarkers market is experiencing significant growth driven by the increasing prevalence of chronic diseases and advancements in digital health technologies. Digital biomarkers refer to objective, quantifiable physiological data collected and analyzed through digital devices or platforms. These biomarkers provide valuable insights into an individual's health status, disease progression, and response to treatment. The digital biomarkers market is experiencing significant growth...
PR Newswire
25/07/2024

Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its…

"We are proud to have achieved ISO 13485:2016 certification at such an early point in our company's history," said Yuling Luo, Ph.D., Chairman, Founder and CEO of Alamar "This certification is a testament to the hard work and dedication of our entire team. It demonstrates our commitment to maintaining the highest standards of quality and safety in our products, ensuring that we meet the needs of our customers and the regulatory requirements of the medical device industry."…
PR Newswire
25/07/2024

Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)

Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024) Attachment 2024 Ipsen Half-Year Financial Report
Nasdaq GlobeNewswire
25/07/2024

A New Era for Healthcare in Kazakhstan: Unveiling Astana Genetic Center…

The AGC laboratory, located at the National Center for Biotechnology of Kazakhstan, is equipped with the latest DNA sequencing and genomic data analysis equipment. It aims to serve as a vital center for conducting tests that will enhance the health of the Kazakhstani population. The AGC laboratory, located at the National Center for Biotechnology ofKazakhstan, is equipped with the latest DNA sequencing and genomic data analysis equipment. It aims to serve as a vital center for conducting...
PR Newswire
25/07/2024

New Studies Validate the Value of Brainomix AI Technology Across US Stroke…

The FDA-cleared Brainomix 360 Stroke platform is powered by state-of-the-art AI algorithms that provide real-time interpretation of brain scans to aid treatment and transfer decisions for stroke patients, with the aim of enabling more patients to receive the right treatment, in the right place, at the right time. DrMichalis Papadakis , CEO and Co-Founder of Brainomix, said: "The studies presented this week at SNIS symbolize our ongoing commitment to scientific excellence and...
PR Newswire
25/07/2024

AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for…

AC Immune's ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer's Disease Treatment of first randomized person with preclinical AD expected this quarterPhase 2b ReTain trial is fully funded and conducted by development partnerLausanne, Switzerland, July 25, 2024– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that its active-immunotherapy candidate,...
Nasdaq GlobeNewswire
25/07/2024

Collateral Ligament Stabilizer System Market is Projected to Reach USD 4.9…

Continuous improvements in medical technology, such as minimally invasive surgical techniques and better implant materials, enhance the effectiveness and appeal of these systems. The trend towards personalized medicine is leading to the development of customized stabilizer systems tailored to individual patient needs, improving outcomes. Continuous improvements in medical technology, such as minimally invasive surgical techniques and better implant materials, enhance the effectiveness and...
PR Newswire
25/07/2024

Phenylketonuria Treatment Market to Reach $1.62 Billion by 2034, with 7.8% CAGR…

Advancements in phenylketonuria treatment technologies, including new gene therapy approaches, enzyme replacement therapies, and innovative medical food formulations, are significantly progressing. These developments enhance patient compliance and treatment effectiveness, expanding the market size for phenylketonuria treatments. Advancements in phenylketonuria treatment technologies, including new gene therapy approaches, enzyme replacement therapies, and innovative medical food formulations,...
PR Newswire
25/07/2024

Thyseed and BASF Announce Strategic Partnership to Drive High-quality Growth in…

At the event, Mr. Wang traced Thyseed's history in the infant feeding products sector since its establishment in 2016, highlighting the company's unwavering commitment to its "Design from Love" product philosophy, which places user needs and experiences at the forefront of all innovations. Thyseed's introduction of transition feeding bottles, with sales topping five million units, illustrates its robust market presence and the strong trust it has cultivated among consumers. At the…
PR Newswire
25/07/2024

Clinical Data Analytics Market Size to Reach US$ 614.7 billion by 2034: Seizing…

The global clinical data analytics market is witnessing significant growth driven by several key factors. One primary factor contributing to this growth is the increasing incidence of chronic diseases worldwide. Chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders are placing a substantial burden on healthcare systems globally. The global clinical data analytics market is witnessing significant growth driven by several key factors. One primary factor...
PR Newswire
25/07/2024

Blood Transfusion Diagnostics Market to Attain a Valuation of US$ 7.7 Billion by…

The rising global prevalence of blood disorders, such as anemia, hemophilia, and leukemia, necessitates the need for accurate and reliable diagnostic tests to assess blood compatibility and identify potential risks associated with transfusions. The rising global prevalence of blood disorders, such as anemia, hemophilia, and leukemia, necessitates the need for accurate and reliable diagnostic tests to assess blood compatibility and identify potential risks associated with transfusions. ...
PR Newswire
25/07/2024

Providence St. Joseph Hospital Performs World's First Spine Surgery Using…

FOR IMMEDIATE RELEASEProvidence St. Joseph Hospital Performs World's First Spine Surgery Using eCential Robotics' Open Spine Robot, with Spineart Compatible Implants ORANGE, Calif. July 25, 2024– Providence St. Joseph Hospital announced it has successfully performed the world's first robotic spinal surgery using a new open spine platform byeCential Roboticsto implant aSpineartmedical device.eCential Robotics, a surgical robotics company which developed the open surgical...
Nasdaq GlobeNewswire
25/07/2024
Altri  Comunicati